Pharmaceutical-Biotech Capital Construction Investment Snapshot: Top 10 Projects Near $3 Billion for 2010

Pharmaceutical-Biotech Capital Construction Investment Snapshot: Top 10 Projects Near $3 Billion for 2010

Pharmaceutical-Biotech Capital Construction Investment Snapshot: Top 10 Projects Near $3 Billion for 2010


Attachment: IIR Table - Top 10 U.S. Pharma-Biotech Projects

SUGAR LAND--April 15, 2010--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--With the economy still gyrating between growth and despair, it is gratifying to offer some positive news from the Pharmaceutical-Biotech Industry. As revealed by a recent analysis of active reported projects that are scheduled to begin construction in 2010, according to Industrial Info's Pharmaceutical Tracker - Online Database, the year's top 10 projects represent a total investment value (TIV) of $2.8 billion thus far. For this analysis, none of the referenced projects are sourced from the academic sector, and each carries an average TIV of $280 million.

Subscribe Now!(All Fields Required)

Standard Membership - Free